Compounded tirzepatide may still be available when a licensed clinician determines it is appropriate and a state-licensed 503A pharmacy can lawfully dispense it under current requirements. Availability is not guaranteed and can change. At Chia, compounded tirzepatide is available as tablets or injections after clinician review; compounded drugs are not FDA-approved.
Wondering if tirzepatide is right for you? Take the 3-min clinical quiz.
See if you qualify →Can you still get compounded tirzepatide?
Yes, compounded tirzepatide may be available through a licensed clinician and a state-licensed 503A compounding pharmacy, but availability can change over time. A clinician must decide whether treatment is appropriate for you, and pharmacy dispensing must meet current federal, state, and pharmacy requirements.8
That means no website can responsibly promise that every person can obtain it. A legitimate process begins with health-history review, medication review, and a prescription when clinically appropriate—not a checkout page alone. For a broader overview, see our guide to compounded tirzepatide.
Why availability can vary
Compounding is regulated differently from manufacturing an FDA-approved drug. FDA policy, state pharmacy rules, a pharmacy’s operations, and the facts of a specific prescription can all affect whether a compounded preparation can be dispensed.8 Checking current requirements with the prescribing clinician and dispensing pharmacy matters because rules and supply conditions can change.
Why clinician review matters
Tirzepatide affects blood sugar, appetite, and digestion through GIP and GLP-1 receptor activity.7 A clinician needs to review your health history, current medicines, treatment goals, and potential risks before deciding whether it is a reasonable option. This review is especially important for people with a history of pancreatitis, gallbladder disease, severe gastrointestinal disease, or certain thyroid cancers.7
What is compounded tirzepatide?
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Once-weekly tirzepatide has been studied in randomized trials involving adults with obesity, including the SURMOUNT-1 trial.4
Mounjaro and Zepbound are brand-name medicines containing tirzepatide. They have FDA-approved labeling for specific uses. Compounded tirzepatide is prepared by a compounding pharmacy pursuant to a prescription; it is not an FDA-approved drug and should not be described as a generic, the same as, or interchangeable with a brand-name product.7
How compounded preparations differ from brand-name medicines
An FDA-approved brand-name medicine is reviewed by FDA for its labeled product-specific quality, safety, and effectiveness information. A compounded preparation is made by a pharmacy for a prescription and is not reviewed by FDA in the same way before dispensing.8 The active ingredient may be discussed in clinical research, but trial outcomes for tirzepatide do not establish outcomes for a particular compounded formulation.
What human research says about tirzepatide
Human randomized trials have evaluated tirzepatide for obesity, including maintenance of weight reduction in SURMOUNT-4 and a head-to-head obesity trial against semaglutide.1 2 Other randomized trials evaluated tirzepatide in people with obesity and obstructive sleep apnea, and in people with obesity and heart failure with preserved ejection fraction.3 6 These are studies of tirzepatide as investigated, not proof of results from compounded formulations; individual results vary.
The same studies and FDA labeling also make clear why clinical monitoring matters. Common adverse effects associated with tirzepatide include nausea, diarrhea, vomiting, constipation, abdominal discomfort, and indigestion. Important risks include pancreatitis, gallbladder problems, dehydration-related kidney problems, low blood sugar when used with certain diabetes medicines, and a boxed warning related to thyroid C-cell tumors seen in rodents.7
How do compounded tirzepatide, Mounjaro, and Zepbound differ?
They share the name tirzepatide, but FDA approval status differs. Mounjaro and Zepbound are FDA-approved branded products with separate labeling, while a compounded preparation is dispensed by a pharmacy under a prescription and is not FDA-approved.7
| Option | Source and status | Prescription and oversight | What not to assume |
|---|---|---|---|
| Compounded tirzepatide | Prepared by a state-licensed 503A compounding pharmacy; not FDA-approved.8 | Requires a prescription and clinician evaluation. | Do not assume it is identical to or interchangeable with a brand-name product. |
| Mounjaro | FDA-approved brand-name tirzepatide product with its own labeling.7 | Requires a prescription. | Do not assume its labeled uses or product data apply to a compounded preparation. |
| Zepbound | FDA-approved brand-name tirzepatide product with its own labeling.9 | Requires a prescription. | Do not assume compounded-product quality or outcomes have been FDA evaluated. |
Brand-specific trial and label information can help a clinician understand the active ingredient’s known risks and evidence base. It cannot establish product-specific quality, bioavailability, or clinical outcomes for a compounded preparation. That distinction is important when comparing compounded tirzepatide with Mounjaro or Zepbound.
Who may be considered for tirzepatide treatment?
A clinician considers the whole person—not just a number on a scale. Individual eligibility depends on health history, current medicines, treatment goals, and the potential balance of benefits and harms. Randomized trials enrolled specific populations, so research findings do not automatically apply to every patient.4
- Weight history, metabolic health, and whether obesity or overweight is affecting health.
- Current prescription and nonprescription medicines, especially medicines that can lower blood sugar.
- Personal or family history relevant to the thyroid warning in tirzepatide labeling.7
- Prior pancreatitis, gallbladder disease, significant stomach-emptying problems, kidney concerns, and pregnancy plans.7
- Whether another treatment, nutrition support, activity plan, sleep care, or in-person evaluation may better fit the situation.
A clinician may recommend a different approach if the risks outweigh the likely benefit, if an interaction needs closer management, or if symptoms need in-person assessment. Tirzepatide is not appropriate for every person, and a prescription is never guaranteed.
3-min quiz
Explore clinician-reviewed tirzepatide care
At Chia, compounded tirzepatide is available as tablets or injections after a licensed-provider evaluation. A prescription requires medical review and is not guaranteed. Medications are compounded in the United States by state-licensed 503A pharmacies; compounded medications are not FDA-approved.
What safety questions should you ask before seeking compounded tirzepatide?
Before starting any tirzepatide product, ask how the prescriber will review your risks, monitor symptoms, and coordinate care. Prompt communication about new symptoms matters because gastrointestinal side effects can sometimes become serious, especially when vomiting or diarrhea leads to dehydration.7
- Who is the licensed clinician reviewing my history and current medications?
- Which pharmacy will prepare and dispense the medication, and is it state-licensed?
- How can I verify the prescription, label, instructions, and pharmacy contact information?
- How will follow-up, dose changes, side-effect questions, and refill decisions be handled?
- What symptoms should prompt an urgent call, urgent care visit, or emergency evaluation?
FDA labeling advises patients to seek medical attention for symptoms that may signal serious problems, such as severe or persistent abdominal pain, signs of a serious allergic reaction, or ongoing vomiting and dehydration.7 Do not use medication purchased from unverified “research chemical” sellers or sources that do not require a prescription. Our guide to where to get peptide injections safely explains what to look for in a legitimate care pathway.
How does compounded tirzepatide work at Chia?
At Chia, care starts with an online health questionnaire and licensed-provider review. If the provider finds compounded tirzepatide clinically appropriate, it may be prescribed as tablets or injections and shipped from a US state-licensed 503A compounding pharmacy to your door.
Chia’s tirzepatide tablet plans currently start at $249 per month, and injection plans currently start at $299 per month. Current pricing and treatment details are available on the product page. These are compounded medications, not FDA-approved products, and treatment outcomes are not guaranteed.
| Chia form | Plan starting price | Care considerations |
|---|---|---|
| Tablets | From $249/month | A provider determines whether this form is appropriate and provides individualized instructions. |
| Injection | From $299/month | A provider determines whether this form is appropriate and provides individualized instructions. |
Dosing is provider-guided and can be adjusted over time. Chia also has microdosing plans available when a provider determines that approach is appropriate; microdosing is not a one-size-fits-all protocol and should not be self-directed. Patients can message their care team through the patient portal between visits. For more on legitimate online prescribing, read how to get a compounded tirzepatide prescription online.
How can you get compounded tirzepatide safely online?
Safe online access means a real clinical process, not simply an online order form. A prescription is required, and the clinician should have enough information to make an individualized decision and explain follow-up steps. FDA describes compounded drugs as prescription products that are not FDA-approved.8
- 1Complete an honest health questionnaire and provide your current medications and relevant medical history.
- 2Have a licensed clinician review your information and decide whether treatment is clinically appropriate.
- 3Confirm the dispensing pharmacy, prescription details, price, shipping process, and support pathway before paying.
- 4Follow the clinician’s directions and contact the care team about side effects, medication changes, or questions.
- 5Seek urgent or emergency care rather than online messaging for severe symptoms or possible emergencies.
If you are specifically exploring a lower-dose, provider-managed approach, our article on where to get microdose tirzepatide explains the access and safety questions to ask. Do not follow dosing schedules from social media, forums, or sellers without a prescribing clinician.
What are common questions about compounded tirzepatide?
No. Compounded medications are not FDA-approved. A compounded tirzepatide preparation should not be assumed to be the same as or interchangeable with Mounjaro or Zepbound.
No. A legitimate compounded tirzepatide pathway requires a prescription from a licensed clinician. The clinician must decide whether treatment is appropriate for you.
An online telehealth process may be available when it includes a real clinician evaluation, a prescription when appropriate, and dispensing through a state-licensed pharmacy. Treatment is not guaranteed.
Yes. Chia offers clinician-reviewed compounded tirzepatide in tablet and injection forms. A licensed provider determines whether treatment and a particular form are appropriate.
Yes, Chia has microdosing plans available when provider-guided. Microdosing is an individualized clinical decision, not a standard instruction for everyone.
A licensed clinician should review your health history, current medications, goals, potential side effects, and contraindications before making a prescribing decision.
No. Randomized trials studied tirzepatide, but they do not establish outcomes for a specific compounded formulation. Compounded medications are not FDA-approved, and individual results vary.
3-min quiz
Start with a clinician evaluation
If you want to explore whether compounded tirzepatide may fit your goals, Chia’s online process begins with a health questionnaire and licensed-provider review. See tirzepatide treatment details. A prescription requires medical evaluation and is not guaranteed; compounded medications dispensed by 503A pharmacies are not FDA-approved.
References
- 1.Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024.
- 2.Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. New England Journal of Medicine. 2025.
- 3.Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. New England Journal of Medicine. 2024.
- 4.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
- 5.Jastreboff AM, le Roux CW, Stefanski A, et al. Tirzepatide for Obesity Treatment and Diabetes Prevention. New England Journal of Medicine. 2025.
- 6.Packer M, Zile MR, Kramer CM, et al. Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity. New England Journal of Medicine. 2025.
- 7.U.S. Food and Drug Administration. Mounjaro (tirzepatide) prescribing information. 2026.
- 8.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. 2026.
- 9.U.S. Food and Drug Administration. Zepbound (tirzepatide) prescribing information. 2026.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if tirzepatide is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
